Activated BCR signaling has been suggested as a critical growth pathway in MCL, diffuse large B-cell lymphoma (DLBCL), follicular lymphoma, and B-cell chronic lymphocytic leukemia (CLL) [12–14]. The gene discussed is BCR; the disease is mantle cell lymphoma.